Canaccord Genuity Reaffirms Their Hold Rating on Tilray (TLRY)
Canaccord Genuity analyst Kenric Tyghe maintained a Hold rating on Tilray today and set a price target of C$13.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Tyghe is ranked #1480 out of 12096 analysts.
In addition to Canaccord Genuity, Tilray also received a Hold from TipRanks – OpenAI’s OpenAI Drug Manufacturers – Specialty and Generic in a report issued today. However, on March 1, TipRanks – Anthropic reiterated a Sell rating on Tilray (NASDAQ: TLRY).
Based on Tilray’s latest earnings release for the quarter ending November 30, the company reported a quarterly revenue of $303.85 million and a GAAP net loss of $62.77 million. In comparison, last year the company earned a revenue of $295.06 million and had a GAAP net loss of $119.37 million
Read More on TLRY:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.